[Observations on daraprim and sulfonamide therapy of latent toxoplasmosis in women].
D000962:Antimalarials / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications; D011739:Pyrimethamine; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D014123:Toxoplasmosis
D000962:Antimalarials; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D011739:Pyrimethamine
ANTIMALARIALS/therapeutic use; PREGNANCY/complications; SULFONAMIDES/therapeutic use; TOXOPLASMOSIS/in pregnancy
Spostrzeźenia w toku leczenia preparatem daraprim i sulfonamidami toksoplazmozy utajonej u kobiet.